# Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty

> **NCT00564850** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 37 (actual)

## Conditions studied

- Precocious Puberty

## Interventions

- **DRUG:** Triptorelin pamoate 11.25mg (Decapeptyl® SR)

## Key facts

- **NCT ID:** NCT00564850
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564850, "Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00564850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*